May 24, 2017
The cost of developing new drugs and cures is enormous. A delicate balance between encouraging innovation and controlling the cost of medicines has to be maintained.
May 09, 2017
Consolidation and the requirements of new and personalized drugs are changing the playing field.
March 17, 2017
Slashing drug prices might benefit patients in the short term, but at what cost?
March 01, 2017
In a time of uncertainty across the board, the United States is still "going boldly” ahead, bringing us innovation and constantly adapting its business model.